Home › Seizures › Connecticut › New Haven
Seizures clinical trials in New Haven, CT
4 studies for Seizures are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
RecruitingPhase 1
- Yale University, New Haven
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
RecruitingPhase 3
- Yale School of Medicine - Yale-New Haven Hospital, New Haven
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
RecruitingPhase 2
- Yale University, New Haven
Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
Recruiting
- Yale New Haven Hospital, New Haven
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- New York City, NY13 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Houston, TX9 studies
- Birmingham, AL8 studies
- Miami, FL7 studies
- Boston, MA7 studies
- Cincinnati, OH6 studies
- San Francisco, CA6 studies
- Durham, NC6 studies
- Dallas, TX6 studies
- Chicago, IL5 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer38 studies
- Cancer (all types)35 studies
- Lung Cancer24 studies
- Colorectal Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Metastatic Cancer22 studies
- Prostate Cancer22 studies
- Ovarian Cancer20 studies
- Opioid Overdose19 studies
- Acute Myeloid Leukemia18 studies
- Alcohol Use Disorder (AUD)18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.